We served as lead counsel representing the former owners of a multi-state retail pharmacy chain in connection with a Department of Justice (DOJ) investigation regarding alleged violations of the False Claims Act (FCA) resulting from inaccurate reporting of usual and customary pricing of generic drugs. The case resulted in declination by DOJ and dismissal of the underlying qui tam lawsuit after the filing of a motion to dismiss under the FCA’s first-to-file rule. Reported case: U.S. ex rel. Phillis v. Stephen L. LaFrance Holdings, 2018 WL 4839057 (N.D. Okla. Oct. 4, 2018).
Representation of Retail Pharmacy Owners: U.S. ex rel. Phillips v. Stephen L. LaFrance Holdings, Inc. (N.D. Okla.)
You Also May Be Interested In:
Lead counsel representing emergency department provider and other defendants in qui tam lawsuit alleging violation of licensure laws caused submission of false claims. District court dismissed allegations against the emergency department provider on grounds that alleged regulatory violation did not satisfy standard for FCA materiality set forth in Supreme Court’s Escobar decision. U.S. ex rel. Taylor v. Boyko, 2019 WL 2423283 (S.D. W. Va. Jun. 6, 2019).
Successfully represented a private equity backed portfolio provider and its management company in a voluntary disclosure to HHS-OIG involving improper billing
Lead counsel for a large long-term care company named as a defendant in a FCA qui tam action involving allegations of medically unnecessary services and improper billing